Efficacy of synbiotic supplementation in obesity treatment: A systematic review and meta-analysis of clinical trials

Critical Reviews in Food Science and Nutrition

Volumn 60, Issue 4, 2020, Pages 584-596

  Hadi, Amir ^a   Alizadeh, Kimia ^b   Hajianfar, Hossein ^c   Mohammadi, Hamed ^a   Miraghajani, Maryam ^d,e  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d National Nutrition and Food Technology Research Institute Tehran   (Iran)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

meta analysis; obesity; overweight; synbiotic

Indexed keywords

ANTHROPOMETRY; DIGITAL LIBRARIES; PROBIOTICS; RANDOM PROCESSES; REGRESSION ANALYSIS;

ELECTRONIC DATABASE; META ANALYSIS; OBESITY; OVERWEIGHT; RANDOM EFFECTS MODEL; RANDOMIZED CLINICAL TRIALS; SYNBIOTIC; WEIGHTED MEAN DIFFERENCES (WMD);

NUTRITION;

SYNBIOTIC AGENT;

BODY WEIGHT; HUMAN; META ANALYSIS; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); WAIST CIRCUMFERENCE;

BODY WEIGHT; HUMANS; OBESITY; OVERWEIGHT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYNBIOTICS; WAIST CIRCUMFERENCE;

EID: 85077902157     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2018.1545218     Document Type: Review

References (68)

1. Alhassan, S., S., Kim, A., Bersamin, A., King, and C., Gardner. 2008. Dietary adherence and weight loss success among overweight women: results from the a to Z weight loss study. International Journal of Obesity 32:985.
2. Artham, S. M., C. J., Lavie, R. V., Milani, and H. O., Ventura. 2008. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgraduate Medicine 120 (2):34–41.
3. Asemi, Z., A., Khorrami-Rad, S.-A., Alizadeh, H., Shakeri, and A., Esmaillzadeh. 2014. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clinical Nutrition 33 (2):198–203.
4. Asgharian, A., V., Mohammadi, Z., Gholi, A., Esmaillzade, A., Feizi, and G., Askari. 2017. The effect of synbiotic supplementation on body composition and lipid profile in patients with NAFLD: a randomized, double blind, placebo-controlled clinical trial study. Iranian Red Crescent Medical Journal 19 (4):e42902
5. Azad, Md Abul Kalam, Manobendro, Sarker, Tiejun, Li, and Jie, Yin. 2018. Probiotic species in the modulation of gut microbiota: An overview. BioMed Research International 2018:9478630
6. Bäckhed, F., H., Ding, T., Wang, L. V., Hooper, G. Y., Koh, A., Nagy, C. F., Semenkovich, and J. I., Gordon. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 101 (44):15718–15723.
7. Bäckhed, F., J. K., Manchester, C. F., Semenkovich, and J. I., Gordon. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences 104 (3):979–984.
8. Bahmani, F., M., Tajadadi-Ebrahimi, F., Kolahdooz, M., Mazouchi, H., Hadaegh, A.-S., Jamal, N., Mazroii, S., Asemi, and Z., Asemi. 2016. The consumption of synbiotic bread containing lactobacillus sporogenes and inulin affects nitric oxide and malondialdehyde in patients with type 2 diabetes mellitus: randomized, double-blind, placebo-controlled trial. Journal of the American College of Nutrition 35 (6):506–513.
9. Barczynska, R., K., Bandurska, K., Slizewska, M., Litwin, M., Szalecki, Z., Libudzisz, and J., Kapusniak. 2015. Intestinal microbiota, obesity and Prebiotics. Polish Journal of Microbiology 64 (2):93–100.
10. Barouki, R., P. D., Gluckman, P., Grandjean, M., Hanson, and J. J., Heindel. 2012. Developmental origins of non-communicable disease: implications for research and public health. Environmental Health 11:42.
11. Beserra, B. T., R., Fernandes, V. A., do Rosario, M. C., Mocellin, M. G., Kuntz, and E. B., Trindade. 2015. A systematic review and Meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clinical Nutrition (Edinburgh, Scotland) 34 (5):845–858.
12. Bmi, O. C. 1998. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. NOE Initiative 6 (Suppl 2):51S–209S.
13. Borenstein, M., L. V., Hedges, J. P., Higgins, and H. R., Rothstein. 2011. Introduction to Meta-analysis. Chichester: John Wiley & Sons.
14. Borgeraas, H., L. K., Johnson, J., Skattebu, J. K., Hertel, and J., Hjelmesaeth. 2018. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: A systematic review and Meta‐analysis of randomized controlled trials. Obesity Reviews 19 (2):219–232.
15. Ekhlasi, G., M., Zarrati, S., Agah, A. F., Hosseini, S., Hosseini, S., Shidfar, S. S. S., Aarbshahi, E., Razmpoosh, and F., Shidfar. 2017. Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease. EXCLI Journal 16:278.
16. Eslamparast, T., H., Poustchi, F., Zamani, M., Sharafkhah, R., Malekzadeh, and A., Hekmatdoost. 2014. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study–. The American Journal of Clinical Nutrition 99 (3):535–542.
17. Eslamparast, T., F., Zamani, A., Hekmatdoost, M., Sharafkhah, S., Eghtesad, R., Malekzadeh, and H., Poustchi. 2014. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. British Journal of Nutrition 112 (3):438–445.
18. Esmaeilinezhad, Z., S., Babajafari, Z., Sohrabi, M.-H., Eskandari, S., Amooee, and R., Barati-Boldaji. 2018. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial. Nutrition, Metabolism and Cardiovascular Diseases.
19. Fernandes, R., V. A., do Rosario, M. C., Mocellin, M. G. F., Kuntz, and E., Trindade. 2017. Effects of inulin-type fructans, galacto-oligosaccharides and related synbiotics on inflammatory markers in adult patients with overweight or obesity: A systematic review. Clinical Nutrition (Edinburgh, Scotland) 36 (5):1197–1206.
20. Ferolla, S., C., Couto, L., Costa-Silva, G., Armiliato, C., Pereira, F., Martins, M., Ferrari, E., Vilela, H., Torres, A., Cunha, et al. 2016. Beneficial effect of synbiotic supplementation on hepatic steatosis and anthropometric parameters, but not on gut permeability in a population with nonalcoholic steatohepatitis. Nutrients 8 (7):397.
21. Franz, C. M., M., Huch, H., Abriouel, W., Holzapfel, and A., Gálvez. 2011. Enterococci as probiotics and their implications in food safety. International Journal of Food Microbiology 151 (2):125–140.
22. Gibson, A. A., and A., Sainsbury. 2017. Strategies to improve adherence to dietary weight loss interventions in research and real-world settings. Behavioral Sciences 7:44.
23. Guinane, S. 2013. The effectiveness of probiotics for managing diarrhoea in people with HIV infection: a critically appraised topic. HIV Medicine 14 (3):187–190.
24. Hadi, A., H., Mohammadi, M., Miraghajani, and E., Ghaedi. 2018. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and Meta-analysis of clinical trials: synbiotic supplementation and NAFLD. Critical Reviews in Food Science and Nutrition:1–12.
25. Haghighat, L., and N. F., Crum-Cianflone. 2016. The potential risks of probiotics among HIV-infected persons: Bacteraemia due to Lactobacillus acidophilus and review of the literature. International Journal of STD & AIDS 27:1223–1230.
26. Heymsfield, S. B., J. B., Harp, M. L., Reitman, J. W., Beetsch, D. A., Schoeller, N., Erondu, and A., Pietrobelli. 2007. Why do obese patients not lose more weight when treated with low-calorie diets? a mechanistic perspective. The American Journal of Clinical Nutrition 85 (2):346–354.
27. Higgins, J. P., D. G., Altman, P. C., Gøtzsche, P., Jüni, D., Moher, A. D., Oxman, J., Savović, K. F., Schulz, L., Weeks, and J. A., Sterne. 2011. The cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical Research ed.) 343:d5928
28. John, G. K., L., Wang, J., Nanavati, C., Twose, R., Singh, and G., Mullin. 2018. Dietary alteration of the gut microbiome and its impact on weight and fat mass: a systematic review and Meta-Analysis. Genes 9 (3):167.
29. Kang, Y., and Y., Cai. 2018. The development of probiotics therapy to obesity: A therapy that has gained considerable momentum. Hormones (Athens). 17:141–151
30. Kassaian, N., A., Feizi, A., Aminorroaya, P., Jafari, M. T., Ebrahimi, and M., Amini. 2018. The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial. Acta Diabetologica:1–10.
31. Khalesi, S., D. W., Johnson, K., Campbell, S., Williams, A., Fenning, S., Saluja, and C., Irwin. 2017. Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and Meta-analysis. European Journal of Nutrition 57:1–17.
32. Le Chatelier, E., T., Nielsen, J., Qin, E., Prifti, F., Hildebrand, G., Falony, M., Almeida, M., Arumugam, J.-M., Batto, S., Kennedy, et al. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (7464):541.
33. Louzada, E. R., and S. M. L., Ribeiro. 2018. Synbiotic supplementation, systemic inflammation, and symptoms of brain disorders in elders: A secondary study from a randomized clinical trial. Nutritional Neuroscience:1–8.
34. Macfarlane, S., S., Cleary, B., Bahrami, N., Reynolds, and G., Macfarlane. 2013. Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double‐blind, placebo‐controlled crossover study. Alimentary Pharmacology & Therapeutics 38:804–816.
35. Malaguarnera, Michele, Marco, Vacante, Tijana, Antic, Maria, Giordano, Giuseppe, Chisari, Rosaria, Acquaviva, Silvana, Mastrojeni, Giulia, Malaguarnera, Antonio, Mistretta, Giovanni, Li Volti, and Fabio, Galvano. 2012. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Digestive Diseases and Sciences 57 (2):545–553.
36. Javadi, L., M., Khoshbaten, A., Safaiyan, M., Ghavami, M. M., Abbasi, B. P., Gargari. 2018. Pro-and prebiotic effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease. Asia Pacific Journal of Clinical Nutrition 27 (5):1031–1039.
37. Marović, D. 2008. Elevated body mass index and fatty liver. Srpski Arhiv za Celokupno Lekarstvo 136:122–125.
38. Marteau, P., and P., Seksik. 2004. Tolerance of probiotics and prebiotics. Journal of clinical gastroenterology 38 (6 Suppl):S67–S69.
39. Martinussen, C., K. N., Bojsen-Moller, M. S., Svane, T. F., Dejgaard, and S., Madsbad. 2017. Emerging drugs for the treatment of obesity. Expert Opinion on Emerging Drugs 22 (1):87–99.
40. McCormick, B., I., Stone, and C. A., Team. 2007. Economic costs of obesity and the case for government intervention. Obesity Reviews 8 (s1):161–164.
41. McLoughlin, R. F., B. S., Berthon, M. E., Jensen, K. J., Baines, and L. G., Wood. 2017. Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: a systematic review and Meta-analysis. The American Journal of Clinical Nutrition 106 (3):930–945. ajcn156265.
42. Miraghajani, M., N., Zaghian, A., Dehkohneh, M., Mirlohi, and R., Ghiasvand. 2017a. Probiotic soy milk consumption and renal function among type 2 diabetic patients with nephropathy: A randomized controlled clinical trial. Probiotics Antimicrob Proteins 1–9.
43. Miraghajani, M.,. N., Zaghian, M., Mirlohi, A., Feizi, and R., Ghiasvand. 2017. The impact of probiotic soy milk consumption on oxidative stress among type 2 diabetic kidney disease patients: a randomized controlled clinical trial. Journal of Renal Nutrition 27 (5):317–324.
44. Nasri, K., M., Jamilian, E., Rahmani, F., Bahmani, M., Tajabadi-Ebrahimi, and Z., Asemi. 2018. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. BMC Endocrine Disorders 18:21.
45. Neto, J. V., C. M., De Melo, and S. M. L., Ribeiro. 2013. Effects of three-month intake of synbiotic on inflammation and body composition in the elderly: A pilot study. Nutrients 5 (4):1276–1286.
46. Okeke, F., B. C., Roland, and G. E., Mullin. 2014. The role of the gut microbiome in the pathogenesis and treatment of obesity. Global Advances in Health and Medicine 3 (3):44–57.
47. World Health Organization. 2017. Obesity and Overweight [Fact Sheet; updated October 2017].
48. Panel, NHLBI Obesity Education Initiative Expert. 1998. Treatment guidelines.
49. Park, S., and J.-H., Bae. 2015. Probiotics for weight loss: a systematic review and Meta-analysis. Nutrition Research (New York, N.Y.) 35 (7):566–575.
50. Peña, F., M. L., Mizgier, P., Morales, I., Rios, C., Carrasco-Pozo, E., Diaz, O., Brunser, and M., Gotteland. 2014. Effect of the symbiotics (B. animalis spp. lactis Bb12 and oligofructose) in obese subjects. A randomized, double-blind, controlled clinical trial. Journal of Food and Nutrition Research 2 (8):491–498.
51. Moher, D., A. Liberati, J. Tetzlaff, and D. G. Altman. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151:264–269.
52. Prados-Bo, A., S., Gomez-Martinez, E., Nova, and A., Marcos. 2015. [role of probiotics in obesity management]. Nutricion Hospitalaria 31 (Suppl 1):10–18.
53. Rabiei, S., M., Hedayati, B., Rashidkhani, N., Saadat, and R., Shakerhossini. 2018. The effects of synbiotic supplementation on body mass index, metabolic and inflammatory biomarkers, and appetite in patients with metabolic syndrome: a Triple-Blind randomized controlled trial. Journal of Diet Supply:1–13.
54. Rabiei, S., R., Shakerhosseini, and N., Saadat. 2015. The effects of symbiotic therapy on anthropometric measures, body composition and blood pressure in patient with metabolic syndrome: a triple blind RCT. Medical Journal of the Islamic Republic of Iran. 29:213
55. Sadat Ebrahimi, Z., E., Nasli-Esfahani, A., Nadjarzade, and H., Mozaffari-Khosravi. 2017. Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial. Journal of Diabetes & Metabolic Disorders 16:23.
56. Samimi, M., A., Dadkhah, H. H., Kashani, M., Tajabadi-Ebrahimi, E. S., Hosseini, and Z., Asemi. 2018. The effects of synbiotic supplementation on metabolic status in women with polycystic ovary syndrome: a randomized Double-Blind clinical trial. Probiotics and Antimicrobial Proteins:1–7.
57. Sayari, S., H., Neishaboori, and M., Jameshorani. 2018. Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 24 (3):331.
58. Seganfredo, F., C., Blume, M., Moehlecke, A., Giongo, D., Casagrande, J., Spolidoro, A., Padoin, B., Schaan, and C., Mottin. 2017. Weight‐loss interventions and gut microbiota changes in overweight and obese patients: a systematic review. Obesity Reviews 18 (8):832–851.
59. Soeliman, F. A., and L., Azadbakht. 2014. Weight loss maintenance: a review on dietary related strategies. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences 19:268.
60. Tabrizi, R., M., Moosazadeh, K. B., Lankarani, M., Akbari, S. T., Heydari, F., Kolahdooz, and Z., Asemi. 2017. The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: a systematic review and Meta-analysis of randomized controlled trials. Probiotics and Antimicrobial Proteins 10 (2):329–342.
61. Tajabadi-Ebrahimi, M., N., Sharifi, A., Farrokhian, F., Raygan, F., Karamali, R., Razzaghi, S., Taheri, and Z., Asemi. 2017. A randomized controlled clinical trial investigating the effect of synbiotic administration on markers of insulin metabolism and lipid profiles in overweight type 2 diabetic patients with coronary heart disease. Experimental and Clinical Endocrinology & Diabetes 125:21–27.
62. Trinchieri, V., L., Laghi, B., Vitali, C., Parolin, I., Giusti, D., Capobianco, P., Mastromarino, and C., De Simone. 2017. Efficacy and safety of a multistrain probiotic formulation depends from manufacturing. Frontiers in Immunology 8:1474.
63. Tsai, F., and W. J., Coyle. 2009. The microbiome and obesity: is obesity linked to our gut flora? Current Gastroenterology Reports 11 (4):307–313.
64. Williams, E. P., M., Mesidor, K., Winters, P. M., Dubbert, and S. B., Wyatt. 2015. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Current Obesity Reports 4 (3):363–370.
65. Xavier-Santos, Douglas, Egidio Dorea, Lima, Andréa Name Colado, Simão, Raquel, Bedani, and Susana Marta Isay, Saad. 2018. Effect of the consumption of a synbiotic diet mousse containing Lactobacillus acidophilus La-5 by individuals with metabolic syndrome: a randomized controlled trial. Journal of Functional Foods 41:55–61.
66. Yaturu, S. 2011. Obesity and type 2 diabetes. Journal of Diabetes Mellitus 1 (4):79.
67. Zamani, B., S., Farshbaf, H. R., Golkar, F., Bahmani, and Z., Asemi. 2017. Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition 117 (8):1095–1102.
68. Zhang, Q., Y., Wu, and X., Fei. 2016. Effect of probiotics on body weight and body-mass index: a systematic review and Meta-analysis of randomized, controlled trials. International Journal of Food Sciences and Nutrition 67 (5):571–580.